New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic or Wegovy—potentially impacting access to these medications for millions of people. Here’s what to know going forward.

Pena no longer sees her compounded medication as “sketchy,” and likes that she can customize her own doses at home, to slowly increase the amount she’s taking and stretch her supply.

CHICAGO — Once-weekly semaglutide improved glycemia and reduced weight without increasing hypoglycemia in adults with type 1 diabetes (T1D) and obesity, new research presented at the American ...

A study led by researchers from the University of Queensland has shown that semaglutide, the active component in weight-loss medications such as Ozempic and Wegovy, is effective in promoting weight ...

Patients aged 45 years or older with type 2 diabetes treated from Jan. 1, 2019, to Dec. 31, 2024, with semaglutide, dulaglutide, or empagliflozin were included in the study.

The study included 7881 patients: 6109 and 1772 received semaglutide and tirzepatide, respectively; 80.8% had low maintenance dosages.